304840 Stock Chart & Stats
₩633.00
-₩82.00(-11.47%)
―
--
Day’s Range― - ―
52-Week Range₩600.00 - ₩2,870.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)162.98K
Market Cap
₩17.35B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.27
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding24,320,660
10 Day Avg. Volume254,029
30 Day Avg. Volume162,979
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-109,542.89
Revenue Forecast (FY)₩29.37T
304840 FAQ
What was PeopleBio. Inc.’s price range in the past 12 months?
PeopleBio. Inc. lowest stock price was ₩600.00 and its highest was ₩2870.00 in the past 12 months.
What is PeopleBio. Inc.’s market cap?
PeopleBio. Inc.’s market cap is ₩17.35B.
When is PeopleBio. Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were PeopleBio. Inc.’s earnings last quarter?
Currently, no data Available
Is PeopleBio. Inc. overvalued?
According to Wall Street analysts PeopleBio. Inc.’s price is currently Undervalued.
Does PeopleBio. Inc. pay dividends?
PeopleBio. Inc. does not currently pay dividends.
What is PeopleBio. Inc.’s EPS estimate?
PeopleBio. Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PeopleBio. Inc. have?
PeopleBio. Inc. has 24,320,660 shares outstanding.
What happened to PeopleBio. Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PeopleBio. Inc.?
Currently, no hedge funds are holding shares in KR:304840
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Abpro Bio Co., Ltd.
―
GENOLUTION INC.
―
ENBIO Co., Ltd
―
Xcell Therapeutics, Inc.
―
Finemedix Co., Ltd.
―